BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18056146)

  • 1. Use of parenteral methotrexate significantly reduces the need for biological therapy.
    Bharadwaj A; Agrawal S; Batley M; Hammond A
    Rheumatology (Oxford); 2008 Feb; 47(2):222. PubMed ID: 18056146
    [No Abstract]   [Full Text] [Related]  

  • 2. Early rheumatoid arthritis: combination therapy of doxycycline plus methotrexate versus methotrexate monotherapy.
    Alarcón GS
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):296-7. PubMed ID: 16932705
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduction of serum interleukin 7 levels upon methotrexate therapy in early rheumatoid arthritis correlates with disease suppression.
    van Roon JA; Jacobs K; Verstappen S; Bijlsma J; Lafeber F
    Ann Rheum Dis; 2008 Jul; 67(7):1054-5. PubMed ID: 18556451
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of methotrexate in the management of rheumatoid arthritis in Dakar. Potential pitfalls.
    Ka MM; Diallo S; Mbengue M; Fary Ka E; Moreira Diop T
    Rev Rhum Engl Ed; 1998 Dec; 65(12):799-800. PubMed ID: 9923052
    [No Abstract]   [Full Text] [Related]  

  • 5. Tailor-made therapy in rheumatoid arthritis: fact or fiction?
    Haroon N; Misra R; Aggarwal A
    Isr Med Assoc J; 2008 Feb; 10(2):139-41. PubMed ID: 18432029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheumatoid arthritis: new concepts in disease evolution, pathogenesis, and treatment.
    Paget SA
    Semin Arthroplasty; 1995 Jul; 6(3):132-44. PubMed ID: 10163520
    [No Abstract]   [Full Text] [Related]  

  • 7. Comment on: Use of parenteral methotrexate significantly reduces the need for biological therapy.
    Thornton C; Ong V; Ward J; Kennedy N; Steuer A
    Rheumatology (Oxford); 2008 Sep; 47(9):1438; author reply 1438. PubMed ID: 18617550
    [No Abstract]   [Full Text] [Related]  

  • 8. Methotrexate: vital new information about a middle aged drug.
    Giannini EH
    J Rheumatol; 2002 Oct; 29(10):2031-3. PubMed ID: 12375307
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
    Lee SS; Park YW; Park JJ; Kang YM; Nam EJ; Kim SI; Lee JH; Yoo WH; Lee SI
    Scand J Rheumatol; 2009; 38(1):11-4. PubMed ID: 19191187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of prognostic markets to guide biologic therapies for rheumatoid arthritis.
    D'Arcy CA; Willkens RF
    J Rheumatol; 2002 Dec; 29(12):2662; author reply 2662-3. PubMed ID: 12465172
    [No Abstract]   [Full Text] [Related]  

  • 11. [Methotrexate: mainstay of rheumatoid arthritis treatment].
    Jacobs JW; Bijlsma JW
    Ned Tijdschr Geneeskd; 2009; 153():A879. PubMed ID: 19785862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of caffeine consumption on efficacy of methotrexate in rheumatoid arthritis.
    Nesher G; Mates M; Zevin S
    Arthritis Rheum; 2003 Feb; 48(2):571-2. PubMed ID: 12571869
    [No Abstract]   [Full Text] [Related]  

  • 13. Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritis.
    van der Kooij SM; de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Ewals JA; Han KH; Hazes JM; Kerstens PJ; Peeters AJ; van Zeben D; Breedveld FC; Huizinga TW; Dijkmans BA; Allaart CF
    Arthritis Rheum; 2009 Jan; 61(1):4-12. PubMed ID: 19116965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of methotrexate use in a patient with rheumatoid arthritis and multiple sclerosis.
    Li S; Kaur PP; Berney SN
    J Clin Rheumatol; 2008 Aug; 14(4):241-2. PubMed ID: 18766127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it time to optimize anchor therapy for rheumatoid arthritis?
    Bijlsma JW
    Rheumatology (Oxford); 2012 Jun; 51 Suppl 4():iv1-2. PubMed ID: 22685270
    [No Abstract]   [Full Text] [Related]  

  • 16. Improving pregnancy counseling for women with rheumatoid arthritis taking methotrexate.
    Neeman N; Aronson MD; Schulze JE; Shmerling RH
    Am J Med; 2009 Nov; 122(11):998-1000. PubMed ID: 19854323
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacogenomics in rheumatoid arthritis.
    Ranganathan P
    Methods Mol Biol; 2008; 448():413-35. PubMed ID: 18370240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome and B cell depletion in patients with rheumatoid arthritis receiving rituximab monotherapy in comparison with patients receiving concomitant methotrexate.
    Owczarczyk K; Hellmann M; Fliedner G; Röhrs T; Maizus K; Passon D; Hallek M; Rubbert A
    Ann Rheum Dis; 2008 Nov; 67(11):1648-9. PubMed ID: 18854518
    [No Abstract]   [Full Text] [Related]  

  • 19. Methotrexate therapy in rheumatoid arthritis after failure to sulphasalazine: to switch or to add?
    Schipper LG; Fransen J; Barrera P; den Broeder AA; Van Riel PL
    Rheumatology (Oxford); 2009 Oct; 48(10):1247-53. PubMed ID: 19638454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol crescents and plates in shoulder effusion of a rheumatoid patient.
    Ho S; Srinivasan U; Bevan M
    Rheumatology (Oxford); 2008 Mar; 47(3):377-8. PubMed ID: 18211948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.